Baxter International stock rises 1.82 percent, outperforming competitors in mixed market
Updated
Updated · MarketWatch · Apr 27
Baxter International stock rises 1.82 percent, outperforming competitors in mixed market
7 articles · Updated · MarketWatch · Apr 27
Baxter International shares closed at $18.49 on Monday, still 43.42% below their 52-week high of $32.68.
The stock outperformed Medtronic and Becton Dickinson, which declined, while Stryker rose slightly; trading volume was 7.1 million, below the 50-day average.
The broader market saw the S&P 500 edge up 0.12% and the Dow Jones fall 0.13%, reflecting a mixed session for major indices.
Why did Baxter's stock rise despite a major earnings loss and a grim forecast?
Is Baxter a true value stock or a trap for investors given its operational woes?
Will selling off major businesses fix Baxter's core issues and boost its innovation?
As Baxter pushes digital care, is it prepared for a cyberattack like Stryker's?
How is Baxter fixing its recalled infusion pumps to ensure patient safety moving forward?